Selected research
Market Outlook & Growth Opportunities
Global Spring-loaded Core Biopsy Device Market Outlook and Growth Opportunities 2026
Market perspective
The global Spring-loaded Core Biopsy Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Spring-loaded Core Biopsy Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Spring-loaded Core Biopsy Device market include Hologic, INRAD, IZI Medical, Merit Medical, Mammotome and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Spring-loaded Core Biopsy Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Spring-loaded Core Biopsy Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Spring-loaded Core Biopsy Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Spring-loaded Core Biopsy Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Spring-loaded Core Biopsy Device Segment by Company
Hologic
INRAD
IZI Medical
Merit Medical
Mammotome
Medtronic
Spring-loaded Core Biopsy Device Segment by Type
Fully Automatic
Semi-Automatic
Spring-loaded Core Biopsy Device Segment by Application
Hospital
Clinic
Spring-loaded Core Biopsy Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Spring-loaded Core Biopsy Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Spring-loaded Core Biopsy Device market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Spring-loaded Core Biopsy Device significant trends, drivers, influence factors in global and regions.
6. To analyze Spring-loaded Core Biopsy Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spring-loaded Core Biopsy Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spring-loaded Core Biopsy Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spring-loaded Core Biopsy Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Spring-loaded Core Biopsy Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spring-loaded Core Biopsy Device industry.
Chapter 3: Detailed analysis of Spring-loaded Core Biopsy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Spring-loaded Core Biopsy Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Spring-loaded Core Biopsy Device in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Fully Automatic
- Semi-Automatic
Applications
- Hospital
- Clinic
Companies covered
- Hologic
- INRAD
- IZI Medical
- Merit Medical
- Mammotome
- Medtronic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 1.2.2 Global Spring-loaded Core Biopsy Device Sales Volume (2021-2032)
- 1.2.3 Global Spring-loaded Core Biopsy Device Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Spring-loaded Core Biopsy Device Market Dynamics
- 2.1 Spring-loaded Core Biopsy Device Industry Trends
- 2.2 Spring-loaded Core Biopsy Device Industry Drivers
- 2.3 Spring-loaded Core Biopsy Device Industry Opportunities and Challenges
- 2.4 Spring-loaded Core Biopsy Device Industry Restraints
3 Spring-loaded Core Biopsy Device Market by Company
- 3.1 Global Spring-loaded Core Biopsy Device Company Revenue Ranking in 2025
- 3.2 Global Spring-loaded Core Biopsy Device Revenue by Company (2021-2026)
- 3.3 Global Spring-loaded Core Biopsy Device Sales Volume by Company (2021-2026)
- 3.4 Global Spring-loaded Core Biopsy Device Average Price by Company (2021-2026)
- 3.5 Global Spring-loaded Core Biopsy Device Company Ranking (2024-2026)
- 3.6 Global Spring-loaded Core Biopsy Device Company Manufacturing Base and Headquarters
- 3.7 Global Spring-loaded Core Biopsy Device Company Product Type and Application
- 3.8 Global Spring-loaded Core Biopsy Device Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Spring-loaded Core Biopsy Device Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Spring-loaded Core Biopsy Device Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Spring-loaded Core Biopsy Device Market by Type
- 4.1 Spring-loaded Core Biopsy Device Type Introduction
- 4.1.1 Fully Automatic
- 4.1.2 Semi-Automatic
- 4.2 Global Spring-loaded Core Biopsy Device Sales Volume by Type
- 4.2.1 Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021-2032)
- 4.2.3 Global Spring-loaded Core Biopsy Device Sales Volume Share by Type (2021-2032)
- 4.3 Global Spring-loaded Core Biopsy Device Sales Value by Type
- 4.3.1 Global Spring-loaded Core Biopsy Device Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Spring-loaded Core Biopsy Device Sales Value by Type (2021-2032)
- 4.3.3 Global Spring-loaded Core Biopsy Device Sales Value Share by Type (2021-2032)
5 Spring-loaded Core Biopsy Device Market by Application
- 5.1 Spring-loaded Core Biopsy Device Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Spring-loaded Core Biopsy Device Sales Volume by Application
- 5.2.1 Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021-2032)
- 5.2.3 Global Spring-loaded Core Biopsy Device Sales Volume Share by Application (2021-2032)
- 5.3 Global Spring-loaded Core Biopsy Device Sales Value by Application
- 5.3.1 Global Spring-loaded Core Biopsy Device Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Spring-loaded Core Biopsy Device Sales Value by Application (2021-2032)
- 5.3.3 Global Spring-loaded Core Biopsy Device Sales Value Share by Application (2021-2032)
6 Spring-loaded Core Biopsy Device Regional Sales and Value Analysis
- 6.1 Global Spring-loaded Core Biopsy Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Spring-loaded Core Biopsy Device Sales by Region (2021-2032)
- 6.2.1 Global Spring-loaded Core Biopsy Device Sales by Region: 2021-2026
- 6.2.2 Global Spring-loaded Core Biopsy Device Sales by Region (2027-2032)
- 6.3 Global Spring-loaded Core Biopsy Device Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Spring-loaded Core Biopsy Device Sales Value by Region (2021-2032)
- 6.4.1 Global Spring-loaded Core Biopsy Device Sales Value by Region: 2021-2026
- 6.4.2 Global Spring-loaded Core Biopsy Device Sales Value by Region (2027-2032)
- 6.5 Global Spring-loaded Core Biopsy Device Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 6.6.2 North America Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 6.7.2 Europe Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 6.9.2 South America Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Spring-loaded Core Biopsy Device Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
7 Spring-loaded Core Biopsy Device Country-level Sales and Value Analysis
- 7.1 Global Spring-loaded Core Biopsy Device Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Spring-loaded Core Biopsy Device Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Spring-loaded Core Biopsy Device Sales by Country (2021-2032)
- 7.3.1 Global Spring-loaded Core Biopsy Device Sales by Country (2021-2026)
- 7.3.2 Global Spring-loaded Core Biopsy Device Sales by Country (2027-2032)
- 7.4 Global Spring-loaded Core Biopsy Device Sales Value by Country (2021-2032)
- 7.4.1 Global Spring-loaded Core Biopsy Device Sales Value by Country (2021-2026)
- 7.4.2 Global Spring-loaded Core Biopsy Device Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.9.2 France Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.16.2 China Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.19.2 India Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Hologic
- 8.1.1 Hologic Company Information
- 8.1.2 Hologic Business Overview
- 8.1.3 Hologic Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Hologic Spring-loaded Core Biopsy Device Product Portfolio
- 8.1.5 Hologic Recent Developments
- 8.2 INRAD
- 8.2.1 INRAD Company Information
- 8.2.2 INRAD Business Overview
- 8.2.3 INRAD Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.2.4 INRAD Spring-loaded Core Biopsy Device Product Portfolio
- 8.2.5 INRAD Recent Developments
- 8.3 IZI Medical
- 8.3.1 IZI Medical Company Information
- 8.3.2 IZI Medical Business Overview
- 8.3.3 IZI Medical Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.3.4 IZI Medical Spring-loaded Core Biopsy Device Product Portfolio
- 8.3.5 IZI Medical Recent Developments
- 8.4 Merit Medical
- 8.4.1 Merit Medical Company Information
- 8.4.2 Merit Medical Business Overview
- 8.4.3 Merit Medical Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Merit Medical Spring-loaded Core Biopsy Device Product Portfolio
- 8.4.5 Merit Medical Recent Developments
- 8.5 Mammotome
- 8.5.1 Mammotome Company Information
- 8.5.2 Mammotome Business Overview
- 8.5.3 Mammotome Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Mammotome Spring-loaded Core Biopsy Device Product Portfolio
- 8.5.5 Mammotome Recent Developments
- 8.6 Medtronic
- 8.6.1 Medtronic Company Information
- 8.6.2 Medtronic Business Overview
- 8.6.3 Medtronic Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Medtronic Spring-loaded Core Biopsy Device Product Portfolio
- 8.6.5 Medtronic Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Spring-loaded Core Biopsy Device Value Chain Analysis
- 9.1.1 Spring-loaded Core Biopsy Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Spring-loaded Core Biopsy Device Sales Mode & Process
- 9.2 Spring-loaded Core Biopsy Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Spring-loaded Core Biopsy Device Distributors
- 9.2.3 Spring-loaded Core Biopsy Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst